U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drug Shortages

FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Report a Drug Shortage | Contact Us | FAQ | Background Info | Get Email Alerts | Download Current Drug Shortages

Start Over | Back to Previous Screen

Leucovorin Calcium Lyophilized Powder for Injection
Status: Currently in Shortage
»Date first posted: No date available
»Therapeutic Categories: Oncology; Pediatric

Expand all

Fresenius Kabi USA, LLC (Revised 09/14/2022)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
200 mg SDV (NDC 63323-710-50) Backordered. Next release September 2022. Check Wholesaler Inventory Demand increase for the drug
500 mg SDV (NDC 63323-711-00) Backordered. Next release September 2022. Check Wholesaler Inventory Manufacturing delay
100 mg per 10 mL (10 mg per mL) Single dose amber vial, liquid (NDC 63323-631-10) Backordered. Next release not available at this time. Check Wholesaler Inventory Manufacturing Delay
500 mg per 50 mL (10 mg per mL) Single dose amber vial, liquid (NDC 63323-631-50) Available Check Wholesaler Inventory Manufacturing Delay

Hikma Pharmaceuticals USA, Inc. (formerly West-Ward) (Revised 01/13/2022)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
50 mg, 10 mL vial (NDC 0143-9555-01) This presentation is temporarily on backorder. Demand increase for the drug
100 mg, 20 mL vial (NDC 0143-9554-01) Inventory is currently available. Demand increase for the drug
200 mg, 30 mL vial (NDC 0143-9553-01) Inventory is currently available. Demand increase for the drug
350 mg, 50 mL vial (NDC 0143-9552-01) Inventory is currently available. Demand increase for the drug

Mylan Institutional, a Viatris company (Reverified 09/28/2022)

Company Contact Information:
800-796-9526

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
100 mg vial (NDC 67457-528-10) Available Demand increase for the drug
200 mg vial (NDC 67457-529-20) Available Demand increase for the drug
350 mg vial (NDC 67457-530-35) Unavailable Re-supply in September 2022. Demand increase for the drug

Sagent Pharmaceuticals (Revised 08/22/2022)

Company Contact Information:
866-625-1618

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
50 mg vial (NDC 25021-813-10) Available. Manufacturing delay
100mg vial (NDC 25021-814-30) Backordered. Estimated availability Oct 2022 Manufacturing delay
200mg vial (NDC 25021-815-30) Available.
350mg vial (NDC 25021-816-30) Available
500mg vial (NDC 25021-828-50) Backordered. Estimated availability Oct 2022 Manufacturing delay

Teva Pharmaceuticals (Reverified 09/21/2022)

Company Contact Information:
800-545-8800

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
100mg/vial, 20mL (NDC 0703-5140-01) Backordered – Estimated date of availability TBD Demand increase for the drug
350mg/vial 30mL (NDC 0703-5145-01) Backordered – Estimated date of availability TBD Demand increase for the drug
Back to Top